Nature Biotechnology, Published online: 10 March 2026; doi:10.1038/s41587-026-03069-5
Deep B cell depletion is delivering transformative clinical results in autoimmune diseases. Dealmakers are wagering on the best tools for the job.
Source: Read Full Article
